Invesco
TRIB

Invesco’s Trinity Biotech TRIB Stock Holding History

Invesco’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-106
Closed -$10K – 3986
2015
Q2 		$10K Buy
106
+1
+1% +$87 ﹤0.01% 4060
2015
Q1 		$10K Buy
105
+12
+13% +$1.11K ﹤0.01% 3966
2014
Q4 		$8K Buy
93
+8
+9% +$689 ﹤0.01% 4013
2014
Q3 		$8K Buy
85
+13
+18% +$1.41K ﹤0.01% 4050
2014
Q2 		$8K Sell
72
-3,840
-98% -$455K ﹤0.01% 4026
2014
Q1 		$474K Buy
3,912
+3,848
+6,013% +$504K ﹤0.01% 3423
2013
Q4 		$8K Buy
64
+1
+2% +$120 ﹤0.01% 4231
2013
Q3 		$7K Buy
63
+46
+271% +$4.48K ﹤0.01% 4239
2013
Q2 		$1K Buy
+17
New +$1.41K ﹤0.01% 4285

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Invesco's TRIB Position: Q3 2015 in Review

Invesco sold out of Trinity Biotech (TRIB) in Q3 2015, closing a stake of 106 shares — an estimated $10K sold.

Invesco first reported a position in TRIB in Q2 2013 and held it in 9 quarters. The position peaked at $474K in Q1 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q3 2015.

  • Invesco reported no remaining Trinity Biotech position as of Q3 2015 after selling out during the quarter.
  • Invesco sold 106 Trinity Biotech shares in Q3 2015, an estimated $10K.
  • Invesco first reported a position in Trinity Biotech in Q2 2013 and held it in 9 quarters.
  • Invesco's Trinity Biotech position peaked at $474K in Q1 2014.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2015.

Based on Invesco's 13F filing for Q3 2015, filed 16 Nov 2015.